Select Harvests (ASX:SHV) lifted underlying NPAT 33% in HY2026, declared a 3.5c dividend and launched a 10% on-market share buy-back.
Champion Iron (ASX:CIA) reported FY2026 Q4 EBITDA of $114m, cut its dividend policy, and confirmed DRPF saleable production is weeks away.
ClearVue Technologies (ASX:CPV) wins a A$600k BIPV contract for Canva’s new Sydney HQ, turning solar glass tech into a marquee reference project.
Acrux (ASX:ACR) signs A$5.4m Lenzetto licensing amendment with Gedeon Richter, bringing the Estradiol spray to Australia’s short MHT market.
HealthCo (ASX:HCW) has landed a WA Government-backed operator for the Mount Private Hospital, reshaping the risk profile of its Healthscope exposure.
Invictus Energy (ASX:IVZ) has executed a Petroleum Production Sharing Agreement with Zimbabwe ahead of the high-impact Musuma-1 exploration well in H2 2026.
Critical Resources (ASX:CRR) reports 3.2 mS cm⁻¹ ionic conductivity on a sulphur-free amorphous solid-state electrolyte, matching sulphide-class performance.
Forrestania Resources (ASX:FRS) returns 21m at 2.50 g/t gold at Lady Lila, lifting the case for a Lake Johnston toll-treatment development path.
GoldArc Resources (ASX:GA8) reported a 106g/t gold intercept at Mt Stirling as its partner-funded 34,000m grade control program crossed halfway.
Blackpearl Group (ASX:BPG) FY26 ARR doubled to $26.8m with 0% DaaS churn, but cash conversion is now the FY27 test investors will be watching.
